CARDIAC REMODELING AFTER INTRAMYOCARDIAL AUTOLOGOUS BONE MARROW MONONUCLEAR CELL THERAPY FOR ISCHEMIC CARDIOMYOPATHY: 2-YEAR ECHOCARDIOGRAPHY RESULTS FROM THE CARDIAMP CELL THERAPY HEART FAILURE TRIAL OPEN-LABEL ROLL-IN COHORT

CardiAMP Cell Therapy (BCDA-01) - BioCardia

Peter Johnston; Lavanya Bellumkonda; Amish N. Raval; R. David Anderson; Debby Holmes-Higgin; Carl J. Pepine; BioCardia; Inc.; Sunnyvale; CA; USA

Jan 4, 2023